MATAWAN, N.J. & EUGENE, Ore., October 14, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) ("Apimeds") today announced the expansion of the Apimeds ai ² Futures Lab program through ...
MATAWAN, N.J. & MOSCOW, Idaho, November 10, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ("Apimeds") today announced the expansion of its ai² Futures Lab™ program ...
The ai² Futures Lab program pairs multidisciplinary student teams with Lokahi Therapeutics leadership to evaluate emerging assets, explore strategic pathways, and develop market-informed ...
The Center for Strategic and International Studies (CSIS) Futures Lab announces a new collaboration with Scale AI, focusing on the integration of advanced AI technologies into international security ...
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) ...